FDA Inspection 1283028 — Zhejiang Huahai Pharmaceutical Technology Co., Ltd.
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical Technology Co., Ltd. on Aug 22, 2025 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 22, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)